Somatic inactivation of Nfl in hematopoietic cells results in a progressive myeloproliferative disorder

被引:141
作者
Le, DT
Kong, N
Zhu, Y
Lauchle, JO
Aiyigari, A
Braun, BS
Wang, E
Kogan, SC
Le Beau, MM
Parada, L
Shannon, KM
机构
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[3] Univ Texas, SW Med Ctr, Dallas, TX USA
[4] Univ Chicago, Hematol Oncol Sect, Dept Med, Chicago, IL 60637 USA
[5] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
关键词
D O I
10.1182/blood-2003-08-2650
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The NF1 tumor suppressor gene encodes a guanosine triphosphotase (GTPase)activating protein that negatively regulates Ras signaling and is inactivated in a subset of juvenile myelomonocytic leukemias (JMMLs). Adoptive transfer of fetal liver cells from Nf1 mutant mice models JMML; however, this system has important limitations as a platform for performing biologic and preclinical studies. We have exploited the interferon-inducible Mx1-Cre transgene to ablate a conditional mutant Nf1 allele in hematopoietic cells. Somatic inactivation of Nf1 induces a myeloproliferative disorder with 100% penetrance that is associated with a subacute clinical course, tissue infiltration by myeloid cells, hypersensitivity to granulocyte-macrophage colony stimulating factor, hyperproliferation, and resistance to apoptosis. These Mx1-Cre, Nf1(flox/flox) mice establish a tractable experimental model for testing therapeutics and for identifying mutations that cooperate with hyperactive Ras in myeloid leukemogenesis. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:4243 / 4250
页数:8
相关论文
共 54 条
[1]   Juvenile myelomonocytic leukemia [J].
Arico, M ;
Biondi, A ;
Pui, CH .
BLOOD, 1997, 90 (02) :479-488
[2]   NEUROFIBROMATOSIS AND CHILDHOOD LEUKEMIA [J].
BADER, JL ;
MILLER, RW .
JOURNAL OF PEDIATRICS, 1978, 92 (06) :925-929
[3]   NEUROFIBROMATOSIS TYPE-1 AND RAS-MEDIATED SIGNALING - FILLING IN THE GAPS [J].
BERNARDS, A .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1995, 1242 (01) :43-59
[4]   Nf1 and Gmcsf interact in myeloid leukemogenesis [J].
Birnbaum, RA ;
O'Marcaigh, A ;
Wardak, Z ;
Zhang, YY ;
Dranoff, G ;
Jacks, T ;
Clapp, DW ;
Shannon, KM .
MOLECULAR CELL, 2000, 5 (01) :189-195
[5]   PROTEINS REGULATING RAS AND ITS RELATIVES [J].
BOGUSKI, MS ;
MCCORMICK, F .
NATURE, 1993, 366 (6456) :643-654
[6]   Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells [J].
Bollag, G ;
Clapp, DW ;
Shih, S ;
Adler, F ;
Zhang, YY ;
Thompson, P ;
Lange, BJ ;
Freedman, MH ;
McCormick, F ;
Jacks, T ;
Shannon, K .
NATURE GENETICS, 1996, 12 (02) :144-148
[7]  
BOS JL, 1989, CANCER RES, V49, P4682
[8]   TARGETED DISRUPTION OF THE NEUROFIBROMATOSIS TYPE-1 GENE LEADS TO DEVELOPMENTAL ABNORMALITIES IN HEART AND VARIOUS NEURAL CREST-DERIVED TISSUES [J].
BRANNAN, CI ;
PERKINS, AS ;
VOGEL, KS ;
RATNER, N ;
NORDLUND, ML ;
REID, SW ;
BUCHBERG, AM ;
JENKINS, NA ;
PARADA, LF ;
COPELAND, NG .
GENES & DEVELOPMENT, 1994, 8 (09) :1019-1029
[9]   A PMLRAR alpha transgene initiates murine acute promyelocytic leukemia [J].
Brown, D ;
Kogan, S ;
Lagasse, E ;
Weissman, I ;
Alcalay, M ;
Pelicci, PG ;
Atwater, S ;
Bishop, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2551-2556
[10]   A PILOT-STUDY OF ISOTRETINOIN IN THE TREATMENT OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA [J].
CASTLEBERRY, RP ;
EMANUEL, PD ;
ZUCKERMAN, KS ;
COHN, S ;
STRAUSS, L ;
BYRD, RL ;
HOMANS, A ;
CHAFFEE, S ;
NITSCHKE, R ;
GUALTIERI, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (25) :1680-1684